11 research outputs found

    Results of the docking procedures for LASSBio-1586.

    No full text
    <p><b>(A)</b> Conformations obtained from the most populous and stable cluster in the binding site of COX-2; <b>(B)</b> most stable docked conformation for LASSBio-1586 (Binding Energy = −7.84 Kcal/mol); <b>(C)</b> native conformation of meloxicam (magenta) and most stable conformation for LASSBio-1586 (cyan).</p

    LASSBio-1586, an <i>N</i>-acylhydrazone derivative, attenuates nociceptive behavior and the inflammatory response in mice - Fig 2

    No full text
    <p><b>Effect of LASSBio-1586 (10, 20 and 40 mg/kg, p.o.), morphine (10 mg/kg, i.p.) and indomethacin (20 mg/kg, i.p.) in the first (A) and second (B) phases of the formalin-induced nociception test in mice (n = 6, per group).</b> Values are expressed as the mean ± SEM, where <i>a</i> indicates <i>p</i><0.05, significantly different from the control group, according to ANOVA, followed by Tukey’s test.</p

    LASSBio-1586, an <i>N</i>-acylhydrazone derivative, attenuates nociceptive behavior and the inflammatory response in mice - Fig 3

    No full text
    <p><b>Effect of LASSBio-1586 (40 mg/kg, p.o.), LASSBio-1586 (40 mg/kg, p.o.) + ondansetron (OND 0.5 mg/kg, i.p.) and LASSBio-1586 (40 mg/kg, p.o.) + L-NAME (10 mg/kg, i.p.) in the first (A) and second (B) phases of the formalin-induced nociception test in mice (n = 6, per group).</b> Values are expressed as the mean ± S.E.M., where <i>a</i> indicates <i>p</i><0.05, significantly different from the control group, according to ANOVA, followed by Tukey’s test.</p
    corecore